CSIMarket
 


Ceres Ventures, Inc.  (CEVE)
Other Ticker:  
 
 

CEVE's Net Cash Flow Growth by Quarter and Year

Ceres Ventures,'s Net Cash Flow results by quarter and year




CEVE Net Cash Flow (in millions $) FY 2012 FY 2011 FY 2010 FY 2009
IV Quarter December - 0.13 0.00 0.00
III Quarter September -0.02 0.00 0.00 0.00
II Quarter June 0.03 0.00 0.00 0.00
I Quarter March -0.11 0.00 0.00 0.00
FY   -0.10 0.13 0.00 0.00



CEVE Net Cash Flow third quarter 2012 Y/Y Growth Comment
Ceres Ventures, Inc. in the third quarter 2012 recorded net cash outflow of $ -0.02 millions.

According to the results reported in the third quarter 2012, Ceres Ventures, Inc. achieved the best Net Cash Flow growth in Major Pharmaceutical Preparations industry. While Ceres Ventures, Inc.' s Net Cash Flow no change of % ranks overall at the positon no. in the third quarter 2012.




CEVE Net Cash Flow ( Y/Y Growth %) 2012
2011 2010 2009
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Ceres Ventures,'s third quarter 2012 Net Cash Flow $ -0.02 millions CEVE's Income Statement
Ceres Ventures,'s third quarter 2011 Net Cash Flow $ 0.00 millions Quarterly CEVE's Income Statement
New: More CEVE's historic Net Cash Flow Growth >>


CEVE Net Cash Flow (Quarter on Quarter Growth %)

2012
2011 2010 2009
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Cash Flow third quarter 2012 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow third quarter 2012 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2009, 2010, 2011, 2012

Ceres Ventures,'s Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CEVE's III. Quarter Q/Q Net Cash Flow Comment
Current results of -0.02 millions by Ceres Ventures, Inc. come out even worse if you take a look at 0.03 millions net cash outflow in the second quarter.

Within Major Pharmaceutical Preparations industry Ceres Ventures, Inc. achieved highest sequential Net Cash Flow growth. While Ceres Ventures,'s Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CEVE's III. Quarter Q/Q Net Cash Flow Comment
Recent results of -0.02 millions by Ceres Ventures, Inc. look even less good considering the net cash outflow 0.03 millions a quarter before.

Within Major Pharmaceutical Preparations industry Ceres Ventures, Inc. achieved highest sequential Net Cash Flow growth. While Ceres Ventures,'s Net Cash Flow growth quarter on quarter, overall rank is .


Ceres Ventures,'s 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2012)
12 Months Ending
(Jun 30 2012)
12 Months Ending
(Mar 31 2012)
12 Months Ending
(Dec 31 2011)
12 Months Ending
Cumulative Net Cash Flow 12 Months Ending $ 0.02 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment


Ceres Ventures, Inc. achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment


Ceres Ventures, Inc. achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
CEVE's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for CEVE's Competitors
Net Cash Flow Growth for Ceres Ventures,'s Suppliers
Net Cash Flow Growth for CEVE's Customers

You may also want to know
CEVE's Annual Growth Rates CEVE's Profitability Ratios CEVE's Asset Turnover Ratio CEVE's Dividend Growth
CEVE's Roe CEVE's Valuation Ratios CEVE's Financial Strength Ratios CEVE's Dividend Payout Ratio
CEVE's Roa CEVE's Inventory Turnover Ratio CEVE's Growth Rates CEVE's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Sep 30 2012 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Sep 30 2012
Allergan plc-19.47%$ -19.466 millions
Bard C R Inc-24.28%$ -24.283 millions
Pfizer Inc-25.16%$ -25.165 millions
Abbvie inc -32.60%$ -32.604 millions
Abbott Laboratories-32.60%$ -32.604 millions
Beam Therapeutics Inc -79.73%$ -79.735 millions
Atyr Pharma Inc -80.84%$ -80.843 millions
Merck and Co Inc -81.87%$ -81.867 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com